Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-07-08

FDA Approved: OLANZAPINE — Supplemental Application (Apotex Corp.)

View source ↗

Summary

FDA approved a supplemental application from Apotex Corp. for olanzapine, authorizing a generic olanzapine product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • olanzapine (olanzapine)

Snippet

SUPPL AP for OLANZAPINE (OLANZAPINE)